Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04785677 · ClinicalTrials.gov registry record · NA
Researching Resiliency in Stressful Experiences (RISE) Program for Men Leaving Incarceration
A NA study, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 403
- Enrollment target
NCT04785677: Completed NA study, sponsored by Florida State University.
NCT04785677 is a NA study that has completed, run by Florida State University. The registered enrollment target is 403 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04785677, a NA study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 403 participants
- Enrollment target
Study Summary
The investigators are conducting a randomized controlled trial to assess the impact of Resiliency in Stressful Experiences (RISE) - a comprehensive trauma-based program for young men releasing from a southeastern state's prisons. The investigators are assessing whether treating trauma and providing other transitional supports - such as employment assistance - as young men return home will help to improve their community stability and enhance their psychological well-being, in turn, resulting in less likelihood that a person will become incarcerated in the future.
Primary Outcome
Stable housing was defined as living in one's own room, apartment, or house, or with family, with an expected duration of residence of 4 months or more, or tenancy rights. A 10- item measure will assess housing stability.
Interventions
- BEHAVIORAL Resiliency in Stressful Experiences (RISE) Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 403 participants |
| Start Date | 2021-02-09 |
| Est. Completion | 2024-06-30 |
| Phase | NA |
What the finished NCT04785677 record still lists
NCT04785677 is an interventional study that assigns participants to a tested intervention. The registered 403 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 1 intervention - of which Resiliency in Stressful Experiences (RISE) Program is the first listed.
NCT04785677 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04785677 about?
NCT04785677 is a clinical study titled "Researching Resiliency in Stressful Experiences (RISE) Program for Men Leaving Incarceration". The investigators are conducting a randomized controlled trial to assess the impact of Resiliency in Stressful Experiences (RISE) - a comprehensive trauma-based program for young men releasing from a southeastern state's prisons. The investigators are assessing whether treating trauma and providing ...
What is the current status of trial NCT04785677?
This trial is currently completed. It is a NA study. The enrollment target is 403 participants. The study started on 2021-02-09. Estimated completion is 2024-06-30.
What interventions are being tested in trial NCT04785677?
The interventions under investigation include: Resiliency in Stressful Experiences (RISE) Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04785677?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04785677's enrollment target sits among peer trials
403 244th of 2000 higher than 1,756 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05647122 · 403 participants · Phase 1
First in Human Study of AZD9592 in Solid Tumors
- NCT05674799 · 403 participants · NA
NDPP-NextGen: A Clinical Trial to Reduce Intergenerational Obesity and Diabetes Risks
- NCT06244771 · 403 participants · Phase 1
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
- NCT05049057 · 404 participants · Phase 2
Treatment of Acute PTH With a CGRP Receptor mAb in Military Service Members and Civilians With mTBI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI